Piper Jaffray Cuts Price Target on Zumiez, Inc. (ZUMZ) Following 4Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Jefferies Remains Sidelined on Zumiez, Inc. (ZUMZ) Following 4Q Results
March 11, 2016 8:49 AM ESTJefferies reiterated a Hold rating on Zumiez, Inc. (NASDAQ: ZUMZ), and raised the price target to $20.00 (from $17.00), as the company's 4Q results exceed expectations. Good expense control helped ZUMZs 4Q EPS come in 4c ahead of consensus expectations. However, the struggles... More
After-Hours Stock Movers 03/10: (SSKN) (ULTA) (FNSR) Higher; (FXCM) (ZUMZ) (LOCO) Lower (more...)
March 10, 2016 6:02 PM ESTSTRATA Skin Sciences, Inc. (NASDAQ: SSKN) 35.2% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) approved STRATAs PMA supplement for the MelaFind System.
FXCM Inc. (NYSE: FXCM) 18.6% LOWER; Leucadia National Corporation (NYSE: LUK) and FXCM Inc. (NYSE: FXCM) announced that they have entered into a memorandum of understanding (the MOU) to amend the terms of their Amended and Restated Credit Agreement (the Credit Agreement), and... More
Zumiez, Inc. (ZUMZ) Reports In-Line Q4 EPS
March 10, 2016 4:07 PM ESTZumiez, Inc. (NASDAQ: ZUMZ) reported Q4 EPS of $0.50, in-line with the analyst estimate of $0.50. Revenue for the quarter came in at $242.4 million versus the consensus estimate of $241.1 million.
Comparable sales for the 13-week period ended January 30, 2016 decreased 9.5% compared to an 8.3% increase for the 13-week period... More
Trading Radar for 3/10: Dollar General (DG), Canadian Solar (CSIQ), Plug Power (PLUG), Veifone (PAY) Report
March 9, 2016 2:56 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
BioLineRx (Nasdaq: BLRX) - consensus loss $0.06
CECO Environmental (Nasdaq: CECE) - consensus EPS $0.21
Canadian Solar (Nasdaq: CSIQ) - consensus EPS $0.76
Cantel Medical (NYSE: CMN) - consensus EPS $0.34
Cardiome Pharma (Nasdaq:... More
